Press / Medias
Health and Life Science deals
Sep 28, 2017
LNC Therapeutics, a French company specializing in the research and development of gut microbiota directed drugs for the treatment of obesity and associated cardiometabolic diseases, raised €6.5 million ($7.7 million) in Series C funding.
In the same category
Press / Medias
EMA & FDA Apply a Similar Mindset When Providing Scientific Advice For Live Biotherapeutic...
Sep 13, 2021
more +
Press / Medias
Press / Medias